115TH CONGRESS 

1ST SESSION S. 920 

AN ACT 

To establish a National Clinical Care Commission. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

†S 920 ES

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘National Clinical Care 

3 Commission Act’’. 

4 SEC. 2. NATIONAL CLINICAL CARE COMMISSION. 

5 (a) ESTABLISHMENT.—There is hereby established, 

6 within the Department of Health and Human Services, 

7 a National Clinical Care Commission (in this section re8 ferred to as the ‘‘Commission’’) to evaluate and make rec9 ommendations regarding improvements to the coordina10 tion and leveraging of programs within the Department 

11 and other Federal agencies related to awareness and clin12 ical care for at least one, but not more than two, complex 

13 metabolic or autoimmune diseases resulting from issues 

14 related to insulin that represent a significant disease bur15 den in the United States, which may include complications 

16 due to such diseases. 

17 (b) MEMBERSHIP.— 

18 (1) IN GENERAL.—The Commission shall be 

19 composed of the following voting members: 

20 (A) The heads of the following Federal 

21 agencies and departments, or their designees: 

22 (i) The Centers for Medicare & Med23 icaid Services. 

24 (ii) The Agency for Healthcare Re25 search and Quality. 
3 

†S 920 ES

1 (iii) The Centers for Disease Control 

2 and Prevention. 

3 (iv) The Indian Health Service. 

4 (v) The Department of Veterans Af5 fairs. 

6 (vi) The National Institutes of 

7 Health. 

8 (vii) The Food and Drug Administra9 tion. 

10 (viii) The Health Resources and Serv11 ices Administration. 

12 (ix) The Department of Defense. 

13 (x) The Department of Agriculture. 

14 (xi) The Office of Minority Health. 

15 (B) Twelve additional voting members ap16 pointed under paragraph (2). 

17 (2) ADDITIONAL MEMBERS.—The Commission 

18 shall include additional voting members, as may be 

19 appointed by the Secretary, with expertise in the 

20 prevention, care, and epidemiology of any of the dis21 eases and complications described in subsection (a), 

22 including one or more such members from each of 

23 the following categories: 

24 (A) Physician specialties, including clinical 

25 endocrinologists, that play a role in the preven-
4 

†S 920 ES

1 tion or treatment of diseases and complications 

2 described in subsection (a). 

3 (B) Primary care physicians. 

4 (C) Non-physician health care profes5 sionals. 

6 (D) Patient advocates. 

7 (E) National experts, including public 

8 health experts, in the duties listed under sub9 section (c). 

10 (F) Health care providers furnishing serv11 ices to a patient population that consists of a 

12 high percentage (as specified by the Secretary) 

13 of individuals who are enrolled in a State plan 

14 under title XIX of the Social Security Act or 

15 who are not covered under a health plan or 

16 health insurance coverage. 

17 (3) CHAIRPERSON.—The members of the Com18 mission shall select a chairperson from the members 

19 appointed under paragraph (2). 

20 (4) MEETINGS.—The Commission shall meet at 

21 least twice, and not more than four times, a year. 

22 (5) VACANCIES.—A vacancy on the Commission 

23 shall be filled in the same manner as the original ap24 pointments. 
5 

†S 920 ES

1 (c) DUTIES.—The Commission shall evaluate and 

2 make recommendations, as appropriate, to the Secretary 

3 of Health and Human Services and Congress regarding— 

4 (1) Federal programs of the Department of 

5 Health and Human Services that focus on pre6 venting and reducing the incidence of the diseases 

7 and complications described in subsection (a); 

8 (2) current activities and gaps in Federal ef9 forts to support clinicians in providing integrated, 

10 high-quality care to individuals with the diseases and 

11 complications described in subsection (a); 

12 (3) the improvement in, and improved coordina13 tion of, Federal education and awareness activities 

14 related to the prevention and treatment of the dis15 eases and complications described in subsection (a), 

16 which may include the utilization of new and exist17 ing technologies; 

18 (4) methods for outreach and dissemination of 

19 education and awareness materials that— 

20 (A) address the diseases and complications 

21 described in subsection (a); 

22 (B) are funded by the Federal Govern23 ment; and 

24 (C) are intended for health care profes25 sionals and the public; and 
6 

†S 920 ES

1 (5) whether there are opportunities for consoli2 dation of inappropriately overlapping or duplicative 

3 Federal programs related to the diseases and com4 plications described in subsection (a). 

5 (d) OPERATING PLAN.—Not later than 90 days after 

6 its first meeting, the Commission shall submit to the Sec7 retary of Health and Human Services and the Congress 

8 an operating plan for carrying out the activities of the 

9 Commission as described in subsection (c). Such operating 

10 plan may include— 

11 (1) a list of specific activities that the Commis12 sion plans to conduct for purposes of carrying out 

13 the duties described in each of the paragraphs in 

14 subsection (c); 

15 (2) a plan for completing the activities; 

16 (3) a list of members of the Commission and 

17 other individuals who are not members of the Com18 mission who will need to be involved to conduct such 

19 activities; 

20 (4) an explanation of Federal agency involve21 ment and coordination needed to conduct such ac22 tivities; 

23 (5) a budget for conducting such activities; and 

24 (6) other information that the Commission 

25 deems appropriate. 
7 

†S 920 ES

1 (e) FINAL REPORT.—By not later than 3 years after 

2 the date of the Commission’s first meeting, the Commis3 sion shall submit to the Secretary of Health and Human 

4 Services and the Congress a final report containing all of 

5 the findings and recommendations required by this sec6 tion. 

7 (f) SUNSET.—The Commission shall terminate 60 

8 days after submitting its final report, but not later than 

9 the end of fiscal year 2021. 

Passed the Senate September 6, 2017. 

Attest: 

Secretary. 
115TH CONGRESS 

1ST SESSION S. 920 

AN ACT 

To establish a National Clinical Care Commission.